Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Oncology Institute (TOI) Shares Issued (2020 - 2025)

Oncology Institute's Shares Issued history spans 5 years, with the latest figure at -$1.5 million for Q4 2025.

For Q4 2025, Shares Issued changed N/A year-over-year to -$1.5 million; the TTM value through Dec 2025 reached $5.6 million, changed N/A, while the annual FY2025 figure was $13.8 million, N/A changed from the prior year.
Shares Issued reached -$1.5 million in Q4 2025 per TOI's latest filing, down from $4.8 million in the prior quarter.
In the past five years, Shares Issued ranged from a high of $15.4 million in Q1 2025 to a low of -$13.0 million in Q2 2025.
Average Shares Issued over 4 years is $569909.1, with a median of $73000.0 recorded in 2024.
The largest YoY upside for Shares Issued was 20939.73% in 2025 against a maximum downside of 651050.0% in 2025.
A 4-year view of Shares Issued shows it stood at $442000.0 in 2022, then crashed by 74.43% to $113000.0 in 2023, then crashed by 166.37% to -$75000.0 in 2024, then plummeted by 1924.0% to -$1.5 million in 2025.
Per Business Quant, the three most recent readings for TOI's Shares Issued are -$1.5 million (Q4 2025), $4.8 million (Q3 2025), and -$13.0 million (Q2 2025).